EMP3: Key Regulator of Muscle-Brain Interface and Pain Perception
EMP3: Key Regulator of Muscle-Brain Interface and Pain Perception
EMP3 (HNMP-1) is a protein that is expressed in various tissues of the body, including the brain, heart, and skeletal muscles. It is a key regulator of the muscle-brain interface, and is involved in the control of muscle movement and posture.
EMP3 has also been shown to play a role in the regulation of pain perception and the modulation of pain modalities. It has been shown to interact with various neurotransmitters, including GABA, which is a inhibitory neurotransmitter that is involved in the regulation of pain perception.
In addition to its role in pain modulation, EMP3 has also been shown to be involved in the regulation of motor neuron function. It has been shown to interact with dopamine, a neurotransmitter that is involved in the regulation of motor neuron function, and has been shown to play a role in the regulation of muscle strength and tone.
EMP3 is also involved in the regulation of inflammation, and has been shown to have anti-inflammatory effects. This may be important for the treatment of various inflammatory disorders, such as multiple sclerosis and rheumatoid arthritis.
In addition to its potential therapeutic applications, EMP3 is also of interest as a drug target. EMP3 has been shown to be involved in the regulation of a variety of cellular processes, including cell signaling, protein synthesis, and intracellular signaling. This makes it a potential target for small molecule inhibitors, which could be used to treat a variety of disorders, including pain, inflammation, and muscle control disorders.
EMP3 may also be a biomarker for certain diseases. For example, EMP3 levels have been shown to be elevated in individuals with multiple sclerosis, a demyelinating disorder that is characterized by the progressive loss of nerve cells. This suggests that EMP3 may be a useful biomarker for the diagnosis and assessment of multiple sclerosis.
In conclusion, EMP3 is a protein that is expressed in various tissues of the body and is involved in the regulation of muscle-brain interface, pain perception, and motor neuron function. It is also involved in the regulation of inflammation and has been shown to have anti-inflammatory effects. As a result, EMP3 is a potential drug target and may be useful as a biomarker for the diagnosis and assessment of various disorders. Further research is needed to fully understand the role of EMP3 in these processes and to develop effective treatments.
Protein Name: Epithelial Membrane Protein 3
Functions: Probably involved in cell proliferation and cell-cell interactions
More Common Targets
EMSLR | EMSY | EMX1 | EMX2 | EMX2OS | EN1 | EN2 | ENAH | ENAM | ENC1 | ENDOD1 | ENDOG | Endogenous Retrovirus group K Env polyprotein (ERVK) | Endogenous retrovirus group K member 25 Pol protein-like, transcript variant X1 | EndoGlyx-1 | Endoplasmic reticulum collagen prolyl 3-hydroxylation complex | Endothelin receptor | Endothelin-Converting Enzymes (ECE) | Endothiapepsin | ENDOU | ENDOV | ENG | ENGASE | ENHO | ENKD1 | ENKUR | ENO1 | ENO1-AS1 | ENO1P1 | ENO1P4 | ENO2 | ENO3 | ENO4 | ENOPH1 | eNoSC Complex | ENOSF1 | ENOX1 | ENOX1-AS2 | ENOX2 | ENPEP | ENPP1 | ENPP2 | ENPP3 | ENPP4 | ENPP5 | ENPP6 | ENPP7 | ENPP7P10 | ENPP7P12 | ENPP7P7 | ENSA | ENSAP2 | ENTHD1 | ENTPD1 | ENTPD1-AS1 | ENTPD2 | ENTPD3 | ENTPD3-AS1 | ENTPD4 | ENTPD5 | ENTPD6 | ENTPD7 | ENTPD8 | ENTR1 | ENTREP1 | ENTREP2 | ENTREP3 | env | ENY2 | EOGT | EOLA1 | EOLA1-DT | EOLA2 | EOLA2-DT | EOMES | EP300 | EP300-AS1 | EP400 | EP400P1 | EPAS1 | EPB41 | EPB41L1 | EPB41L1-AS1 | EPB41L2 | EPB41L3 | EPB41L4A | EPB41L4A-AS1 | EPB41L4A-DT | EPB41L4B | EPB41L5 | EPB42 | EPC1 | EPC2 | EPCAM | EPCAM-DT | EPDR1 | EPG5 | EPGN | EPHA1 | EPHA1-AS1